These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7089280)

  • 1. Subjective vs. objective evaluation of gallbladder opacification during oral cholecystography in comparative clinical trials: implications for studies involving visual assessment.
    Fon GT; Hunter TB; Berk RN; Patton DD; Capp MP
    Radiology; 1982 Jul; 144(2):277-80. PubMed ID: 7089280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs.
    Hunter TB; Fon GT; Berk RN; Capp MP
    Gastrointest Radiol; 1981; 6(4):349-52. PubMed ID: 7308718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical trial of oral cholecystography using combinations of contrast agents and two consecutive doses.
    Thoeni RF; Moss AA
    Radiology; 1982 Jul; 144(2):271-5. PubMed ID: 7045975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined use of oral cholecystopaque media and iodipamide.
    Goergen T; Goldberger LE; Berk RN
    Radiology; 1974 Jun; 111(3):543-8. PubMed ID: 4828985
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
    Martinez DS; Chopra IJ
    Panminerva Med; 2003 Mar; 45(1):53-7. PubMed ID: 12682620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography].
    Ipinza I
    Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral cholecystopaques: iopronic acid vs. iopanoic acid.
    Amberg JR; Goldberger LA; Bates M
    Radiology; 1980 Jan; 134(1):31-2. PubMed ID: 6985742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cholecystography in the early phase of acute alcoholic pancreatitis. A prospective, randomized comparison of Telepaque and Bilopaque.
    Smith HJ; Corbett DB; Loeb PM; Peterson WL
    Invest Radiol; 1982; 17(6):629-33. PubMed ID: 6759457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional oral cholecystography versus single-visit oral cholecystography.
    Nathan MH; Newman A
    Am J Gastroenterol; 1981 Dec; 76(6):527-9. PubMed ID: 7331984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of fasting on opacification of the gallbladder during oral cholecystography using two consecutive doses in a canine model.
    Thoeni RF; Moss AA; Stoughton JA
    Invest Radiol; 1979; 14(3):228-32. PubMed ID: 468495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of diarrhea on gallbladder opacification during oral cholecystography: comparison of two cholecystographic agents (author's transl)].
    Fukuda K; Nanjo M; Harada J; Sekiya T; Kanehira Y; Anno I; Takayama M; Watanabe H; Yamada T; Yamaguchi M; Tada S
    Rinsho Hoshasen; 1979 Mar; 24(3):379-84. PubMed ID: 547079
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of iocetamic acid and sodium iopodate in cholecystography.
    Golberg B
    Radiol Clin (Basel); 1977; 46(1):42-9. PubMed ID: 136669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the results of a clinical study of the x-ray specific activity of the Soviet x-ray contrast medium bilimin, intended for peroral cholecystography and cholecystocholangiography].
    Rozenshtraukh LS; Rabkin IKh; Absava GI
    Vestn Rentgenol Radiol; 1985; (2):19-23. PubMed ID: 4013059
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.